Structures and functions of coronavirus replication–transcription complexes and their relevance for SARS-CoV-2 drug design

B Malone, N Urakova, EJ Snijder… - … Reviews Molecular Cell …, 2022 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has killed millions of
people and continues to cause massive global upheaval. Coronaviruses are positive-strand …

Molnupiravir: A lethal mutagenic drug against rapidly mutating severe acute respiratory syndrome coronavirus 2—A narrative review

S Masyeni, M Iqhrammullah… - Journal of Medical …, 2022 - Wiley Online Library
Broad‐spectrum antiviral agents targeting viral RNA‐dependent RNA polymerase (RdRp)
are expected to be a key therapeutic strategy in the ongoing coronavirus disease 2019 …

Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant

M Pachetti, B Marini, F Benedetti, F Giudici… - Journal of translational …, 2020 - Springer
Background SARS-CoV-2 is a RNA coronavirus responsible for the pandemic of the Severe
Acute Respiratory Syndrome (COVID-19). RNA viruses are characterized by a high mutation …

Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach

SO Aftab, MZ Ghouri, MU Masood, Z Haider… - Journal of translational …, 2020 - Springer
Abstract Background The Severe acute respiratory syndrome-related coronavirus 2 (SARS-
CoV-2) outbreak originating in Wuhan, China, has raised global health concerns and the …

[PDF][PDF] Antivirals with common targets against highly pathogenic viruses

L Lu, S Su, H Yang, S Jiang - Cell, 2021 - cell.com
Historically, emerging viruses appear constantly and have cost millions of human lives.
Currently, climate change and intense globalization have created favorable conditions for …

SARS-CoV-2 RNA polymerase as target for antiviral therapy

L Buonaguro, M Tagliamonte, ML Tornesello… - Journal of Translational …, 2020 - Springer
A new human coronavirus named SARS-CoV-2 was identified in several cases of acute
respiratory syndrome in Wuhan, China in December 2019. On March 11 2020, WHO …

Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA‐dependent RNA polymerase (RdRp) inhibition: an in-silico analysis

S Singh, MF Sk, A Sonawane, P Kar… - Journal of …, 2021 - Taylor & Francis
The sudden outburst of Coronavirus disease (COVID-19) caused by the Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses a massive threat to global public …

Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory …

S Koulgi, V Jani, MVN Uppuladinne, U Sonavane… - RSC …, 2020 - pubs.rsc.org
The efforts towards developing a potential drug against the current global pandemic, COVID-
19, have increased in the past few months. Drug development strategies to target the RNA …

Beyond the approved: target sites and inhibitors of bacterial RNA polymerase from bacteria and fungi

SH Kirsch, FPJ Haeckl, R Müller - Natural Product Reports, 2022 - pubs.rsc.org
Covering: 2016 to 2022 RNA polymerase (RNAP) is the central enzyme in bacterial gene
expression representing an attractive and validated target for antibiotics. Two well-known …

In silico investigation on the inhibitory effect of fungal secondary metabolites on RNA dependent RNA polymerase of SARS-CoV-II: A docking and molecular dynamic …

KS Ebrahimi, M Ansari, MSH Moghaddam… - Computers in biology …, 2021 - Elsevier
Abstract The newly emerged Coronavirus Disease 2019 (COVID-19) rapidly outspread
worldwide and now is one of the biggest infectious pandemics in human society. In this …